ITM Isotope Technologies Munich Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
607
- Latest Deal Type
-
M&A
- (Announced)
- Financing Rounds
-
12
- Investments
-
3
ITM Isotope Technologies Munich General Information
Description
Manufacturer of medical radioisotopes designed for precision oncology applications. The company offers non-carrier-added lutetium-177, actinium-225, gallium-68, automated theranostics synthesizers, radiopharmaceutical conjugates, and medical radioisotopes, providing oncology centers with targeted diagnostic and therapeutic tools to improve patient outcomes.
Contact Information
Website
www.itm-radiopharma.comCorporate Office
- Walther-von-Dyck-Strasse 4
- 85748 Munich
- Germany
Corporate Office
- Walther-von-Dyck-Strasse 4
- 85748 Munich
- Germany
ITM Isotope Technologies Munich Timeline
ITM Isotope Technologies Munich Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ITM Isotope Technologies Munich Comparisons
Industry
Financing
Details
ITM Isotope Technologies Munich Competitors (53)
One of ITM Isotope Technologies Munich’s 53 competitors is Kazia Therapeutics, a Corporation company based in Sydney, Australia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kazia Therapeutics | Corporation | Sydney, Australia | ||||
| Navidea Biopharmaceuticals | Corporate Backed or Acquired | Columbus, OH | ||||
| RadioMedix | Venture Capital-Backed | Houston, TX | ||||
| Bridge Medicines | Venture Capital-Backed | New York, NY | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA |
ITM Isotope Technologies Munich Patents
ITM Isotope Technologies Munich Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4822714-A1 | 68ge/68ga generator | Pending | 08-Apr-2025 | ||
| WO-2026215071-A1 | 68ge/68ga generator | Pending | 08-Apr-2025 | ||
| EP-4763231-A1 | Para-aminohippuric acid as a stabilizer in radiopharmaceutical compositions | Pending | 20-Dec-2024 | ||
| WO-2026133265-A1 | Para-aminohippuric acid as a stabilizer in radiopharmaceutical compositions | Pending | 20-Dec-2024 | ||
| AU-2025259463-A1 | Stable formulations comprising 225-actinium labeled complexes and methods for preparing the same | Pending | 15-Apr-2024 | A61K51/0497 |
ITM Isotope Technologies Munich Signals
ITM Isotope Technologies Munich Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
ITM Isotope Technologies Munich Investments (3)
ITM Isotope Technologies Munich’s most recent deal was a Joint Venture with Actineer. The deal was made on 18-Oct-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Actineer | 18-Oct-2023 | Joint Venture | Monitoring Equipment | ||
| Positron Precision | 18-Aug-2022 | Buyout/LBO | Other Healthcare Technology Systems | ||
| Joint Venture (Chengdu Gaotong Isotope / ITM) | 13-Sep-2021 | Joint Venture | Drug Discovery |
ITM Isotope Technologies Munich Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Silk Road Precision Oncologics | Garching Bei Munchen, Germany | 2017 | |
| Itg Alpha | Garching Bei Munchen, Germany | 2017 |
ITM Isotope Technologies Munich FAQs
-
When was ITM Isotope Technologies Munich founded?
ITM Isotope Technologies Munich was founded in 2004.
-
Where is ITM Isotope Technologies Munich headquartered?
ITM Isotope Technologies Munich is headquartered in Munich, Germany.
-
What is the size of ITM Isotope Technologies Munich?
ITM Isotope Technologies Munich has 607 total employees.
-
What industry is ITM Isotope Technologies Munich in?
ITM Isotope Technologies Munich’s primary industry is Biotechnology.
-
Is ITM Isotope Technologies Munich a private or public company?
ITM Isotope Technologies Munich is a Private company.
-
What is the current valuation of ITM Isotope Technologies Munich?
The current valuation of ITM Isotope Technologies Munich is .
-
What is ITM Isotope Technologies Munich’s current revenue?
The current revenue for ITM Isotope Technologies Munich is .
-
How much funding has ITM Isotope Technologies Munich raised over time?
ITM Isotope Technologies Munich has raised $878M.
-
Who are ITM Isotope Technologies Munich’s investors?
Petrichor Healthcare Capital Management, RV Invest, Serial Stage Venture Partners, Athos (Family Office), and BlackRock are 5 of 14 investors who have invested in ITM Isotope Technologies Munich.
-
Who are ITM Isotope Technologies Munich’s competitors?
Kazia Therapeutics, Navidea Biopharmaceuticals, RadioMedix, Bridge Medicines, and Genentech are some of the 53 competitors of ITM Isotope Technologies Munich.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process